FindTrial
Sign In

Diagnosis of cervical cancer using developed 3D imaging method.

Development of 3D imaging method for the diagnosis of cervical cancer - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/085899
Enrollment
60
Registered
2025-04-29
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C53- Malignant neoplasm of cervix uteri

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Manipal Academy of Higher Education(MAHE), Manipal.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The slides where cells were adequate and the cytopathologist could provide the diagnosis.

Exclusion criteria

Exclusion criteria: Slides where cytopathologist reported inadequate bloody smear.

Design outcomes

Primary

MeasureTime frame
The proposed 3D imaging method will be used to record the images and study the morphological parameters of the healthy and malignant cervical cells. Also, the proposed method will be helpful for the diagnosis of cervical cancer.Timepoint: 3 Years 6 Months—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactVarad Mahesh Phadke

Manipal Institute of Applied Physics(FKA Dept. of Atomic and Molecular Physics),MAHE, Manipal.

varad.dampmpl2023@learner.manipal.edu7083489883

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026